Animal Antibacterial Peptide Market

Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.

Animal Antibacterial Peptide Market contains market size and forecasts of Animal Antibacterial Peptide in global, including the following market information:

• Global Animal Antibacterial Peptide Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Animal Antibacterial Peptide Market Sales, 2017-2022, 2023-2028, (K MT)
• Global top five Animal Antibacterial Peptide companies in 2021 (%)

The global Animal Antibacterial Peptide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Anionic Peptides Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Animal Antibacterial Peptide include Merial, Zoetis, Bayer HealthCare, Merck Animal Health, Elanco (Eli Lilly and Company), Biogenesis Bago, Animal Medics and Boehringer Ingelheim Vetmedica, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Animal Antibacterial Peptide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Animal Antibacterial Peptide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Animal Antibacterial Peptide Market Segment Percentages, by Type, 2021 (%)

• Anionic Peptides
• Cationic Peptide

Global Animal Antibacterial Peptide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Animal Antibacterial Peptide Market Segment Percentages, by Application, 2021 (%)

• Poultry
• Livestock

Global Animal Antibacterial Peptide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Animal Antibacterial Peptide Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Animal Antibacterial Peptide revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Animal Antibacterial Peptide revenues share in global market, 2021 (%)
• Key companies Animal Antibacterial Peptide sales in global market, 2017-2022 (Estimated), (K MT)
• Key companies Animal Antibacterial Peptide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merial
• Zoetis
• Bayer HealthCare
• Merck Animal Health
• Elanco (Eli Lilly and Company)
• Biogenesis Bago
• Animal Medics
• Boehringer Ingelheim Vetmedica